Schedule 13D ownership disclosure
Durata Therapeutics, Inc.
Security class unavailable · CUSIP: 26658A107
Event date: 2014-05-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950142-14-001158
- Form type
- SC 13D
- Filer
- AISLING CAPITAL III LP
- CIK
- CIK 1444717
- Filed
- May 28, 2014
- Reporting period
- May 20, 2014
- Description
- Schedule 13D beneficial ownership